Please login to the form below

Not currently logged in
Email:
Password:

Parexel appoints CEO

Jamie Macdonald succeeds co-founder Josef von Rickenbach

Jamie MacdonaldBiopharmaceutical services provider, Parexel, has appointed Jamie Macdonald as its chief executive officer (CEO), a role that will see him succeed Josef von Rickenbach.

Macdonald previously led INC Research, now known as Syneos Health, for several years first as CEO and most recently as vice chairman.

He has also served as senior vice president and head of global project management at Quintiles, now IQVIA.

Macdonald said: “As a trail blazer in the biopharmaceutical services industry, the company enjoys well-deserved recognition as having the kind of deep therapeutic and functional expertise, global reach and innovative capability to continue its leadership.

“I am humbled to have the opportunity to build on this legacy and look forward to continued growth and excellence for Parexel.”

20th March 2018

From: Sales

Share

Tags

PMEA Awards 2020

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Viseven

Viseven is a full cycle digital agency with 10 years expertise in developing content for the global pharmaceutical market delivering...

Latest intelligence

01 PME-APR21 Cover.jpg
Virtual congresses: video thrilled the cardio tsar
Chris Ross explores the key learnings from a year of virtual congresses...
When Will We Be Back To Normal?
The definitive question of 2021, whether you’re a homeschooling parent, a homebound professional, a wanderer with nowhere to go… or all three at once....
How to tell your healthcare story.
Healthcare research is not a simple story and the people in charge of those moments need to be careful about the story that they tell....

Infographics